CD123/CLL1 CAR-T Cell Therapy (Fujian Medical University) |
|
Phase 3 Clinical |
Fujian Medical University |
Leukemia, Myeloid, Acute |
Details
|
Flotetuzumab |
S-80880; MGD-006; RES-234 |
Phase 2 Clinical |
Macrogenics Inc |
Leukemia, Myelogenous, Chronic; Hematologic Neoplasms; Leukemia; Leukemia, Hairy Cell; Mastocytosis, Systemic; Hodgkin Disease; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Neoplasms, Plasma Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, Biphenotypic, Acute |
Details
|
Talacotuzumab |
CSL-362; JNJ-473; CSL-362-AML; JNJ-56022473; IL-13 MAb-CSL |
Phase 2 Clinical |
Csl Ltd |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
Vibecotamab |
XmAb-14045 |
Phase 2 Clinical |
Xencor Inc |
Leukemia, Myeloid; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
Pivekimab sunirine |
IMGN-632 |
Phase 2 Clinical |
Immunogen Inc |
Bone Marrow Neoplasms; Leukemia; Myeloproliferative Disorders; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
CD123 CAR-T cell therapy(Chongqing Precision Biotechnology) |
|
Phase 2 Clinical |
Chongqing Precision Biotechnology Co Ltd |
Leukemia; Leukemia, Myeloid; Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T-cell therapy (Southwest Hospital) |
|
Phase 2 Clinical |
Southwest Hospital Chongqing |
Leukemia, Myeloid |
Details
|
AZD-9829 |
AZD-9829; AZD9829 |
Phase 2 Clinical |
Astrazeneca Plc |
Hematologic Diseases; Hematologic Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
Anti Tim-3/CD123 CAR-T Cell Therapy(Xuzhou Medical University) |
|
Phase 2 Clinical |
Xuzhou Medical University (Xzmu), The Affiliated Hospital Of Xuzhou Medical University |
Leukemia, Myeloid, Acute |
Details
|
MP0533 |
MP0533 |
Phase 2 Clinical |
Molecular Partners Ag |
Leukemia, Myeloid, Acute |
Details
|
APVO-436 |
APVO-436; APVO436 |
Phase 2 Clinical |
Aptevo |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
SAR-443579 |
SAR-443579; SAR443579; SAR579; IPH6101; IPH-6101 |
Phase 2 Clinical |
Sanofi |
Hematologic Diseases; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, B-Cell; Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T-cell therapy (University of Pennsylvania/Novartis) |
JEZ-567 |
Phase 1 Clinical |
Novartis Pharma Ag, University Of Pennsylvania |
Leukemia, Myeloid, Acute |
Details
|
UCART-123 |
UCART-123 |
Phase 1 Clinical |
Cellectis Sa |
Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
JNJ-63709178 |
JNJ-9178; CNTO-9958; JNJ-63709178 |
Phase 1 Clinical |
Johnson & Johnson Innovative Medicine, Genmab A/S |
Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T cell therapy (Shanghai GeneChem) |
|
Phase 1 Clinical |
Shanghai Genechem Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
IM-23 (Beijing Immunochina Medical Science and Technology) |
IM-23; IM-23 CAR-T |
Phase 1 Clinical |
Beijing Immunochina Medical Science & Technology Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T-cell therapy (Nanjing Legend Biotech) |
|
Phase 1 Clinical |
|
Leukemia, Myeloid, Acute |
Details
|
MB-102 (Mustang Bio) |
MB-102 |
Phase 1 Clinical |
Mustang Bio Inc, City Of Hope National Medical Center |
Neoplasm, Residual; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Biphenotypic, Acute |
Details
|
UniCAR-T-CD-123 |
UniCAR-T-CD123; AVC-101 |
Phase 1 Clinical |
AvenCell Therapeutics Inc, AvenCell Europe GmbH |
Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR-T cell therapy (Wuhan Union Hospital) |
|
Phase 1 Clinical |
Wuhan BioRaid Biotechnology Co Ltd, Wuhan Union Hospital |
Leukemia, Myeloid, Acute |
Details
|
CD123 CAR-T cells (Hebei Senlang Biotechnology) |
|
Phase 1 Clinical |
Hebei Senlang Biological Technology Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
ACLX-002 |
ACLX-002 |
Phase 1 Clinical |
Arcellx Inc |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
MGD-024 |
MGD-024 |
Phase 1 Clinical |
Macrogenics Inc |
Leukemia, Myelogenous, Chronic; Leukemia, Hairy Cell; Hodgkin Disease; Myelodysplastic Syndromes; Neoplasms; Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, B-Cell; Leukemia, Myeloid, Acute |
Details
|
AFM-28 |
AFM-28 |
Phase 1 Clinical |
Affimed |
Leukemia, Promyelocytic, Acute; Neoplasms; Leukemia, Myeloid, Acute |
Details
|
VIP943 |
BAY-943; VIP-943 |
Phase 1 Clinical |
Bayer AG |
Myelodysplastic Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
CD123 CAR-NK cell therapy(Beijing JD Biotech) |
JD123; JD-123 |
Phase 1 Clinical |
Peking University People'S Hospital, Beijing JD Biotech Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Universal CAR-T Cells therapy(Shenzhen Geno-Immune Medical Institute) |
|
Phase 1 Clinical |
Shenzhen Geno-Immune Medical Institute |
Leukemia, Myeloid, Acute |
Details
|
AVC-201 |
AVC-201; Allo-RevCAR01-T-CD123 |
Phase 1 Clinical |
AvenCell Europe GmbH |
Leukemia, Myeloid, Acute |
Details
|
CD123-CAR T cells(St Jude Children's Research Hospital) |
|
Phase 1 Clinical |
St Jude Children's Research Hospital |
Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Burkitt Lymphoma |
Details
|
Allogenic CD123-CAR-NK Cells therapy(JD Biotech) |
JD023 |
Phase 1 Clinical |
Beijing JD Biotech Co Ltd, Chinese Academy Of Military Medical Sciences |
Leukemia, Myeloid, Acute |
Details
|
BYON-4413 |
BYON-4413 |
Phase 1 Clinical |
Byondis Bv |
Hematologic Neoplasms; Leukemia, Myeloid, Acute |
Details
|
GR-1901 |
GR1901; GR-1901 |
Phase 1 Clinical |
Chongqing Zhixiang Jintai Biopharmaceutical Co Ltd, Genrix (Shanghai) Biopharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
SQZ-622(Novartis Pharma) |
SQZ-622 |
Phase 1 Clinical |
Novartis Pharma Ag |
Leukemia, Myeloid, Acute |
Details
|
UniCAR02-T |
UniCAR02-T |
Phase 1 Clinical |
Cellex Patient Treatment Gmbh |
Kidney Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
IL3 CAR T-cell therapy (Yake Biotechnology) |
|
Phase 1 Clinical |
Zhejiang University |
Leukemia, Myeloid, Acute |
Details
|
CD123/CLL1 CAR-T Cell Therapy (Fujian Medical University) |
|
Phase 3 Clinical |
Fujian Medical University |
Leukemia, Myeloid, Acute |
Details
|
Flotetuzumab |
S-80880; MGD-006; RES-234 |
Phase 2 Clinical |
Macrogenics Inc |
Leukemia, Myelogenous, Chronic; Hematologic Neoplasms; Leukemia; Leukemia, Hairy Cell; Mastocytosis, Systemic; Hodgkin Disease; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Neoplasms, Plasma Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, Biphenotypic, Acute |
Details
|
Talacotuzumab |
CSL-362; JNJ-473; CSL-362-AML; JNJ-56022473; IL-13 MAb-CSL |
Phase 2 Clinical |
Csl Ltd |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
Vibecotamab |
XmAb-14045 |
Phase 2 Clinical |
Xencor Inc |
Leukemia, Myeloid; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
Pivekimab sunirine |
IMGN-632 |
Phase 2 Clinical |
Immunogen Inc |
Bone Marrow Neoplasms; Leukemia; Myeloproliferative Disorders; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
CD123 CAR-T cell therapy(Chongqing Precision Biotechnology) |
|
Phase 2 Clinical |
Chongqing Precision Biotechnology Co Ltd |
Leukemia; Leukemia, Myeloid; Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T-cell therapy (Southwest Hospital) |
|
Phase 2 Clinical |
Southwest Hospital Chongqing |
Leukemia, Myeloid |
Details
|
AZD-9829 |
AZD-9829; AZD9829 |
Phase 2 Clinical |
Astrazeneca Plc |
Hematologic Diseases; Hematologic Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
Anti Tim-3/CD123 CAR-T Cell Therapy(Xuzhou Medical University) |
|
Phase 2 Clinical |
Xuzhou Medical University (Xzmu), The Affiliated Hospital Of Xuzhou Medical University |
Leukemia, Myeloid, Acute |
Details
|
MP0533 |
MP0533 |
Phase 2 Clinical |
Molecular Partners Ag |
Leukemia, Myeloid, Acute |
Details
|
APVO-436 |
APVO-436; APVO436 |
Phase 2 Clinical |
Aptevo |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
SAR-443579 |
SAR-443579; SAR443579; SAR579; IPH6101; IPH-6101 |
Phase 2 Clinical |
Sanofi |
Hematologic Diseases; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, B-Cell; Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T-cell therapy (University of Pennsylvania/Novartis) |
JEZ-567 |
Phase 1 Clinical |
Novartis Pharma Ag, University Of Pennsylvania |
Leukemia, Myeloid, Acute |
Details
|
UCART-123 |
UCART-123 |
Phase 1 Clinical |
Cellectis Sa |
Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
JNJ-63709178 |
JNJ-9178; CNTO-9958; JNJ-63709178 |
Phase 1 Clinical |
Johnson & Johnson Innovative Medicine, Genmab A/S |
Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T cell therapy (Shanghai GeneChem) |
|
Phase 1 Clinical |
Shanghai Genechem Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
IM-23 (Beijing Immunochina Medical Science and Technology) |
IM-23; IM-23 CAR-T |
Phase 1 Clinical |
Beijing Immunochina Medical Science & Technology Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR T-cell therapy (Nanjing Legend Biotech) |
|
Phase 1 Clinical |
|
Leukemia, Myeloid, Acute |
Details
|
MB-102 (Mustang Bio) |
MB-102 |
Phase 1 Clinical |
Mustang Bio Inc, City Of Hope National Medical Center |
Neoplasm, Residual; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Biphenotypic, Acute |
Details
|
UniCAR-T-CD-123 |
UniCAR-T-CD123; AVC-101 |
Phase 1 Clinical |
AvenCell Therapeutics Inc, AvenCell Europe GmbH |
Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute |
Details
|
Anti-CD123 CAR-T cell therapy (Wuhan Union Hospital) |
|
Phase 1 Clinical |
Wuhan BioRaid Biotechnology Co Ltd, Wuhan Union Hospital |
Leukemia, Myeloid, Acute |
Details
|
CD123 CAR-T cells (Hebei Senlang Biotechnology) |
|
Phase 1 Clinical |
Hebei Senlang Biological Technology Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
ACLX-002 |
ACLX-002 |
Phase 1 Clinical |
Arcellx Inc |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
MGD-024 |
MGD-024 |
Phase 1 Clinical |
Macrogenics Inc |
Leukemia, Myelogenous, Chronic; Leukemia, Hairy Cell; Hodgkin Disease; Myelodysplastic Syndromes; Neoplasms; Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, B-Cell; Leukemia, Myeloid, Acute |
Details
|
AFM-28 |
AFM-28 |
Phase 1 Clinical |
Affimed |
Leukemia, Promyelocytic, Acute; Neoplasms; Leukemia, Myeloid, Acute |
Details
|
VIP943 |
BAY-943; VIP-943 |
Phase 1 Clinical |
Bayer AG |
Myelodysplastic Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
CD123 CAR-NK cell therapy(Beijing JD Biotech) |
JD123; JD-123 |
Phase 1 Clinical |
Peking University People'S Hospital, Beijing JD Biotech Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Universal CAR-T Cells therapy(Shenzhen Geno-Immune Medical Institute) |
|
Phase 1 Clinical |
Shenzhen Geno-Immune Medical Institute |
Leukemia, Myeloid, Acute |
Details
|
AVC-201 |
AVC-201; Allo-RevCAR01-T-CD123 |
Phase 1 Clinical |
AvenCell Europe GmbH |
Leukemia, Myeloid, Acute |
Details
|
CD123-CAR T cells(St Jude Children's Research Hospital) |
|
Phase 1 Clinical |
St Jude Children's Research Hospital |
Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Burkitt Lymphoma |
Details
|
Allogenic CD123-CAR-NK Cells therapy(JD Biotech) |
JD023 |
Phase 1 Clinical |
Beijing JD Biotech Co Ltd, Chinese Academy Of Military Medical Sciences |
Leukemia, Myeloid, Acute |
Details
|
BYON-4413 |
BYON-4413 |
Phase 1 Clinical |
Byondis Bv |
Hematologic Neoplasms; Leukemia, Myeloid, Acute |
Details
|
GR-1901 |
GR1901; GR-1901 |
Phase 1 Clinical |
Chongqing Zhixiang Jintai Biopharmaceutical Co Ltd, Genrix (Shanghai) Biopharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
SQZ-622(Novartis Pharma) |
SQZ-622 |
Phase 1 Clinical |
Novartis Pharma Ag |
Leukemia, Myeloid, Acute |
Details
|
UniCAR02-T |
UniCAR02-T |
Phase 1 Clinical |
Cellex Patient Treatment Gmbh |
Kidney Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
IL3 CAR T-cell therapy (Yake Biotechnology) |
|
Phase 1 Clinical |
Zhejiang University |
Leukemia, Myeloid, Acute |
Details
|